October, 2011: Maastricht, The Netherlands
Pie Medical Imaging presents the release of CAAS A-Valve during the PCR London Valve (October 16 -18, 2011). CAAS A-Valve allows analysis of the aortic root by creating a 3D reconstruction from two aortographic X-ray images. Based on this 3D reconstruction an optimal projection is calculated, to assist in selection of the C-arm projection for an optimal view of the aortic root and coronary cusps. This optimal projection shows all cusps in the perpendicular and in the Posterior, Right and Left orientation.
CAAS A-Valve provides new analysis tools to clinicians and researchers which allows 3D measurements of the ascending aorta, the sinotubular junction and the sinus of valsalva. Additionally, the diameter of the basal plane and the ostia heights in relation to the basal plane can be measured. The CAAS A-valve is fast and easy to use, and allows minimal integration in the cathlab workflow.
“In Europe, CAAS A-Valve can be used during Transcatheter Aortic Valve Implementation (TAVI) procedures. The established optimal projection helps to determine the positioning depth by providing landmarks. With this we offer a comprehensive solution meeting the needs of physicians.” said Lizet Bary, Product Manager at Pie Medical Imaging.
About Pie Medical Imaging
Pie Medical Imaging B.V. based in Maastricht, the Netherlands, is the worldwide leading company in quantitative analysis software for cardiology and radiology and well known for the CAAS products. Pie Medical Imaging develops and delivers software solutions that drive next-generation diagnostics and research worldwide. Pie Medical Imaging is part of the Esaote group. Esaote S.p.A. is a leading manufacturer of ultrasound equipment and dedicated MRI. More information is available at: www.piemedicalimaging.com.
For further information, please contact, Rene Guillaume, Director Sales and Marketing of Pie Medical Imaging BV, Becanusstraat 13D, 6216 BX Maastricht, The Netherlands, Tel: +31-43-3281328, Email: rene.guillaume@pie.nl.
